Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.930
-0.030 (-1.53%)
Jan 29, 2026, 3:14 PM EST - Market open
Gain Therapeutics Employees
As of December 31, 2024, Gain Therapeutics had 25 total employees, including 23 full-time and 2 part-time employees. The number of employees decreased by 7 or -21.88% compared to the previous year.
Employees
25
Change (1Y)
-7
Growth (1Y)
-21.88%
Revenue / Employee
n/a
Profits / Employee
-$775,670
Market Cap
74.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 25 | -7 | -21.88% | 23 | 2 |
| Dec 31, 2023 | 32 | 1 | 3.23% | 29 | 3 |
| Dec 31, 2022 | 31 | 2 | 6.90% | 28 | 3 |
| Dec 31, 2021 | 29 | 15 | 107.14% | 25 | 4 |
| Dec 31, 2020 | 14 | 10 | 250.00% | 11 | 3 |
| Sep 30, 2020 | 12 | 8 | 200.00% | 9 | 3 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pliant Therapeutics | 171 |
| XBiotech | 88 |
| PolyPid | 60 |
| ALX Oncology Holdings | 44 |
| Equillium | 35 |
| Annovis Bio | 15 |
| Pelthos Therapeutics | 11 |
| Coeptis Therapeutics Holdings | 7 |
GANX News
- 22 days ago - Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week - GlobeNewsWire
- 23 days ago - Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287 - GlobeNewsWire
- 5 weeks ago - Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson's Disease - GlobeNewsWire
- 6 weeks ago - Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson's Disease - GlobeNewsWire
- 2 months ago - Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025 - GlobeNewsWire
- 2 months ago - Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Gain Therapeutics: Valuation Remains Low In Light Of Recently Reported Functional Improvement In PD Patients - Seeking Alpha
- 3 months ago - Gain Therapeutics to Present at Neuroscience 2025 - GlobeNewsWire